Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bile duct cancer
bile duct cancer
FDA greenlights Otsuka subsidiary's bile duct cancer drug
Endpoints
Mon, 10/3/22 - 10:04 am
Otsuka
Taiho Oncology
Lytgobi
bile duct cancer
FDA
With fresh FDA nod, Servier branches targeted drug Tibsovo into bile duct cancer
Fierce Pharma
Fri, 08/27/21 - 10:44 am
Servier
Tibsovo
bile duct cancer
FDA
BridgeBio keeps FDA approval spree rolling, this time with nod for targeted bile duct cancer med
Fierce Pharma
Tue, 06/1/21 - 12:07 pm
Bridge Bio
FDA
Truseltiq
infigratinib
bile duct cancer
Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time
Endpoints
Mon, 04/20/20 - 10:58 am
Incyte
Pemazyre
pemigatinib
bile duct cancer
cholangiocarcinoma
FDA
ESMO: Agios celebrates milestone win for ivosidenib in tough-to-treat bile duct cancer
Fierce Pharma
Mon, 09/30/19 - 10:41 am
Agios
bile duct cancer
Tibsovo
ESMO
